The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




AstraZeneca PLC - AZN AZ regulatory submission in Japan for Forxiga
07:00 21-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN US FDA approves Lokelma for adult hyperkalaemia
07:00 21-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Result of AGM
17:30 18-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN AZN: Q1 2018 Results
07:00 18-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN AstraZeneca update on Fasenra PIII trial in COPD
07:00 11-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN EMA approves Lynparza: maintenance ovarian cancer
11:00 08-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN AZ and Luye Pharma enter agreement for Seroquel
07:00 08-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Director Declaration
12:00 04-May-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN AZ: positive CHMP for Tagrisso first-line nsclc
12:30 27-Apr-2018  RNS  3.36% View chart
Circassia Pharmaceuticals Plc - CIR Issue of Equity - AstraZeneca
07:00 24-Apr-2018  RNS  2.37% View chart
AstraZeneca PLC - AZN AstraZeneca:high level results of the ARCTIC trial
07:00 24-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN FDA approves Tagrisso for 1st-line use in NSCLC
07:00 19-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Notice of AGM
11:00 13-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Directorate Change
07:00 05-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN AZ AND MSD SUBMIT LYNPARZA FOR BREAST CANCER IN EU
07:00 03-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN FDA TO REVIEW MOXETUMOMAB FOR HAIRY CELL LEUKAEMIA
07:00 03-Apr-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Lokelma approved in the EU
16:48 22-Mar-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE
07:00 12-Mar-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Filing of Form 20-F with SEC
07:00 07-Mar-2018  RNS  3.36% View chart
AstraZeneca PLC - AZN Annual Financial Report
11:00 06-Mar-2018  RNS  3.36% View chart

 Page 1 of 2

| 1 | 2 | Next



RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


about rns

 

News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds